US 7335356
Monoclonal antibodies and complementarity-determining regions binding to Ebola glycoprotein
granted A61KA61K2039/505
Quick answer
US patent 7335356 (Monoclonal antibodies and complementarity-determining regions binding to Ebola glycoprotein) held by The United States of America as represented by the Secretary of the Army expires Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Secretary of the Army
- Grant date
- Tue Feb 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K2039/505